Director/PDMR Shareholding

RNS Number : 9651B

GlaxoSmithKline PLC

12 January 2015

 

GlaxoSmithKline plc

Notification of Transactions of Directors, Persons Discharging

Managerial Responsibility or Connected Persons

In accordance with DTR 3.1.4R(1)(a) GlaxoSmithKline plc ('GSK') was advised on 12 January 2015, of changes in the interests of the following Directors and Persons Discharging Managerial Responsibility, following increases in their notional interests in Ordinary Shares and American Depositary Shares (ADSs), at a price of 1379.00 pence per Ordinary Share and $42.11 per ADS, following the re-investment of dividends paid on Ordinary Shares and ADSs held in the GlaxoSmithKline 2009 Deferred Annual Bonus Plan.

Director/PDMR	Number of Ordinary Shares acquired under the personal contribution element of the plan	Number of Ordinary Shares acquired under the matching element of the plan (GSK contribution)
Sir Andrew Witty	2,072	2,072
Mr S Dingemans	912	912
Mr R G Connor	233	233
Mr S A Hussain	117	117
Mr D S Redfern	443	443
Ms C Thomas	334	334
Mr P C Thomson	67	67
Dr P J T Vallance	972	972
Ms E Walmsley	536	536

Director/PDMR	Number of ADSs acquired under the personal contribution element of the plan	Number of ADSs acquired  under the matching element of the plan (GSK contribution)
Dr M M Slaoui	853	853
Mrs D P Connelly	165	165
Mr W C Louv	206	206
Mr D E Troy	378	378

V A Whyte

Company Secretary

12 January 2015

 

END

 

 

RDSVLLFFEFFFBBQ